Biotechnology from bench to business

• Follow GEN on:
• Login | Register | Subscribe

• ADME/Tox
• Automation
• Bioprocess Scale-Up
• Bioreactors
• Biosimilars
• Cell Culture
• Cell-Based Assays
• Contract Manufacturing
• Gene Therapy
• High-Throughput Screening
• Immunoassay
• Induced Pluripotent Stem Cells
• Informatics
• Liquid Handling
• Protein Characterization
• Protein Detection
• Regenerative Medicine
• RNAi/siRNA
• Stem Cells
• Western Blot

BioBusiness

• GEN News Highlights

• More »

• Elan Buys Up AOP Orphan, Large Stake in Newbridge
  
• Grifols Taking Aradigm Stake in Up To $116M Licensing Deal
  
• Phase III Failure for Pfizer NHL Drug
  
• Novo Acquires Anti-Infective Developer Xellia for $700M
  
• Ignyta Snaps Up Actagene, Branches into Cancer Rx/Dx
  

• Insight & Intelligence™

• More »

• GEN Hall of Shame
  May 20, 2013
  Meet the Congressional enemies of research funding.
• Companion Diagnostics: 52 Pick-Up
  May 13, 2013
  Check out our three lists of 52 CDx: those approved by the FDA, those under review right now, and those that may be coming soon.
• Your Genes, Your Choice?
  May 9, 2013
  Critics say the American College of Medical Genetics and Genomics’ recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy.
• GEN Congressional Hall of Fame
  May 6, 2013
  Biomedical research has friends in high places. Meet them.
• Challenge: Surface Sampler
  May 3, 2013
  This is a device originally devised to protect soldiers from biological and chemical warfare. Can you think of a novel way to use this technology? Enter for a shot at prizes!

• Feature Articles

• More »

• People in the News
  
• Emerging Markets Turn to Innovation
  Governments Increasingly Seek to Build Their Economies through Life Science Investments
• U.K. Biopharma Bouncing Back
  Advantages Include 30 Leading Universities and Womb-to-Tomb Electronic Health Records
• Global Bioclusters Vie for Dominance in Battle Royale
  China and India Pose Fierce Competition to U.S. Biopharma
• Telling the Story of Biotechnology
  Life Sciences Foundation Formed to Help People Understand Why Biotech History Matters

• Corporate Profiles

• More »

• Softening the Blow from FOLFOX Treatment
  PledPharma’s Modified Form of Mangafodipir Shown to Reduce Side Effects of Chemotherapy
• Twin Effort Hones In on Membrane Proteins
  Calixar and Synthelis Join Forces to Offer Clients a Range of Services
• Cytomics for Personalized Heart Health
  CytoVas’ Vascular Profile Uses Biomarkers to Test Patients’ Cardiovascular Status
• Exploiting Folate Pathways to Treat Cancer
  Endocyte Uses an Imaging Agent to Select Patients Likely to Respond to Its Therapies
• New England Biolabs Looks Past Enzymes
  

• BioMarket Trends

• More »

• Biotechs Need to Walk the Walk on Drug Value
  Report Finds Gap between How Executives Judge Drug Value vs. Corporate Efficiency
• The Globalization of IVD Companies
  Alluring Emerging Markets Include BRIC Countries As Well As Indonesia and Vietnam
• Exosome Research Publication Landscape
  Examining Current Market Trends and Segments of Research Efforts
• Top 20 Biopharma R&D Spenders
  Which Companies Have the Deepest Pockets for Research and Development?
• Top 10 Biopharma Layoffs of 2012
  Find Out Which Companies Axed the Most Workers Last Year

• Wall Street Biobeat

• More »

• New Study Shows Where to Start Your Start-Up
  U.K. Found to Be Most Favorable Location for Nascent One-Product Companies
• Risks and Perils of Crowdfunding Your Biotech Start-Up
  Practice Could Revolutionize Fundraising for Early-Stage Firms, But Beware of the Pitfalls
• Small Firms Look Optimistically to Future
  J.P. Morgan Healthcare Conference Attendees Share Their Reasons to Anticipate Good Times
• Type 2 Diabetes Drugs Drive Sector Growth
  Firms Use a Range of Strategies to Exploit a Market Expected to Grow to $157B by 2017
• The New Economics of Orphan Diseases
  Opportunities Abound in Rare Disease Space as Market Is Projected to Continue Growing

• GEN Podcasts

• More »

• BIO 2013 Session Preview: “Behind the Tech Transfer Headlines”
  Interview with Jon Soderstrom, Ph.D., managing director of the office of cooperative research at Yale University and moderator of the BIO tech transfer session, and Atul Saran, senior vp of corporate development and ventures at MedImmune
• Biobanking Now and Future Trends
  Interview with Jim Vaught, Ph.D., Deputy Director, NCI Office of Biorepositories and Biospecimen Research
• Disruptive Science and Technology: A New Journal
  Alan Russell, Ph.D., Editor in Chief
• Exploring Biotech’s Past and Predicting Its Future with G. Steven Burrill
  G. Steven Burrill, CEO, Burrill & Company
• Drug Repositioning as a Viable Business Model
  Aris Persidis, Ph.D., President, Biovista

• GEN Polls

• More »

• GEN’s Hall of Shame
  
• Genome Sequencing and Patient Autonomy
  
• FDA: Too Restrictive?
  
• Alzheimer’s Research
  
• Social Media and the News
  

• Events

• More »

• International Biopharmaceutical and Biochemistry Instrument Shanghai Exhibition
  2013 May 27 - May 29 Shanghai, , CHINA
• PDA/FDA Pharmaceutical Supply Chain Workshop
  2013 June 3 - June 5 Bethesda, MD, UNITED STATES
• Measurement of Residual Host Cell Protein and DNA in Biotechnology Products
  2013 June 3 - June 4 Rockville, MD, UNITED STATES
• BIO World Congress on Industrial Biotechnology
  2013 June 16 - June 19 Montreal, PQ, CANADA
• Applications for Enzyme Technologies
  2013 June 17 - June 18 San Francisco, CA, UNITED STATES